Search Results 1091-1100 of 11270 for Antifungal Resistance
The purpose of this trial is to evaluate the effectiveness, safety, and tolerability of a single oral administration of study drug CP101 for the prevention of ...
Mayo Clinic researchers identify molecule linked to treatment-resistant inflammatory bowel disease featured image. Research. Mayo Clinic researchers identify ...
treatment with breast cancer resistance protein (BCRP) inhibitors (e.g., cyclosporine, eltrombopag). Subject is receiving treatment with any of the ...
About this study. This phase I trial studies the best dose and side effects of recombinant vesicular stomatitis virus carrying the human NIS and IFN beta ...
About this study. The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated ...
... resistance protein (BCRP) and/or strong inhibitor of P-glycoprotein (P-gp) enzymes/transporters, sensitive CYP3A substrates with narrow therapeutic index ...
At Mayo Clinic, doctors who are specialists in dermatology, hematology, pathology, radiology, oncology and radiation oncology work with other experts to create ...
Cephalosporin antibiotics are commonly used but can result in allergic reactions and anaphylaxis. There is no clear diagnostic approach for cephalosporin- ...
0) viral, bacterial, or fungal infection within 2 weeks prior to the first dose of study drug. Routine antimicrobial prophylaxis is permitted. Participating ...
... fungal, or viral infection) that may interfere with assessment of HS * History of recurrent or recent serious infection * Known history of significant ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.